These data would appear to suggest that therapies targeting STING would be ineffective in HPV- HNSCC; however, host rather than cancer cell expression of STING has been shown to be critical for therapies targeting STING [6, 10]. This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.